N/A N=13 Supportive Care

A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Bottom Line

View on ClinicalTrials.gov: NCT01119001 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2015

Primary outcome: Primary: Accuracy of Typing With a BCI Keyboard by ALS Patients. — 81; 78; 75 percentage accuracy

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: P300 Brain Computer Interface Keyboard (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Michigan
Primary completion: Aug 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Accuracy of Typing With a BCI Keyboard by ALS Patients.	81; 78; 75	—

Summary

People with Amyotrophic Lateral Sclerosis (ALS) will use a P300 based brain computer interface (BCI) keyboard to type in assistive technology devices. The results of this study will be compared with a previous study of a P300 BCI keyboard used by healthy volunteers.

Eligibility Criteria

Inclusion Criteria

Age 18 or older.
Diagnosed with cerebral palsy, spinal cord injury, neuromuscular disease, or ALS that results in impaired hand and arm function making it difficult to manipulate objects (if at all) and requires help to prepare or modify activities
Able to see the BCI display
Able to give informed consent
Able to understand and remember instructions concerning participation
Able to communicate effectively at least with familiar conversation partners

Exclusion Criteria

Are unable to give informed consent.
Are currently experiencing open head sores
Have a history of photo-sensitive epilepsy
Have a history of cognitive deficits requiring accommodation or special education services
Are unable to sit without moving the head and neck for at least 15 minutes

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01119001). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.